Tzvia Bader

home / authors / tzvia-bader

Articles

The latest podcast episode of Oncology Peer Review On-The-Go features a conversation with Tzvia Bader and Karine Perreault on TrialJectory’s platform, which seeks to guide patients with cancer on their treatment journey.

Oncology Peer Review On-The-Go: Improving Testing Access and Guiding Treatment Options with TrialJectory

Matthew Fowler;Tzvia Bader;Karine Perreault
December 7th 2021

The latest podcast episode of Oncology Peer Review On-The-Go features a conversation with Tzvia Bader and Karine Perreault on TrialJectory’s platform, which seeks to guide patients with cancer on their treatment journey.

Tzvia Bader Discusses the TrialJectory Platform Connecting Patients With Cancer to Clinical Trials

Tzvia Bader Discusses the TrialJectory Platform Connecting Patients With Cancer to Clinical Trials

Tzvia Bader
March 26th 2021

CancerNetwork® spoke with Tzvia Bader about barriers between patients and appropriate clinical trials and how to combat these issues.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
Published: November 8th 2024 | Updated: November 21st 2024
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Published: November 7th 2024 | Updated: November 21st 2024
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?
Published: November 12th 2024 | Updated: November 21st 2024
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?